Owl monkey CCR5 reveals synergism between CD4 and CCR5 in HIV-1 entry

被引:5
|
作者
Nahabedian, John [1 ,2 ]
Sharma, Amit [1 ]
Kaczmarek, Maryska E. [3 ]
Wilkerson, Greg K. [4 ]
Sawyer, Sara L. [3 ]
Overbaugh, Julie [1 ,2 ]
机构
[1] Fred Hutchinson Canc Res Ctr, Human Biol Div, 1124 Columbia St, Seattle, WA 98104 USA
[2] Univ Washington, Pathobiol, Seattle, WA 98195 USA
[3] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Vet Sci, Michale E Keeling Ctr Comparat Med & Res, Bastrop, TX USA
基金
美国国家科学基金会; 美国国家卫生研究院;
关键词
HIV-1; Receptor; Entry; CD4; CCR5; Owl monkey; Species differences; IMMUNODEFICIENCY-VIRUS TYPE-1; AMINO-TERMINUS; CELL-SURFACE; LIVING CELLS; N-TERMINUS; ENV CLONES; INFECTIONS; VARIANTS; RECEPTOR; GP120;
D O I
10.1016/j.virol.2017.09.018
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Studying HIV-1 replication in the presence of functionally related proteins from different species has helped define host determinants of HIV-1 infection. Humans and owl monkeys, but not macaques, encode a CD4 receptor that permits entry of transmissible HIV-1 variants due to a single residue difference. However, little is known about whether divergent CCR5 receptor proteins act as determinants of host-range. Here we show that both owl monkey (Aotus vociferans) CD4 and CCR5 receptors are functional for the entry of transmitted HIV-1 when paired with human versions of the other receptor. By contrast, the owl monkey CD4/CCR5 pair is generally a suboptimal receptor combination, although there is virus-specific variation in infection with owl monkey receptors. Introduction of the human residues 15Y and 16T within a sulfation motif into owl monkey CCR5 resulted in a gain of function. These findings suggest there is cross-talk between CD4 and CCR5 involving the sulfation motif.
引用
收藏
页码:180 / 186
页数:7
相关论文
共 50 条
  • [31] Mice transgenic for human CD4 and CCR5 are susceptible to HIV infection
    Browning, J
    Horner, JW
    Pettoello-Mantovani, M
    Raker, C
    Yurasov, S
    DePinho, RA
    Goldstein, H
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (26) : 14637 - 14641
  • [32] CCR5Δ32 Genotypes in a German HIV-1 Seroconverter Cohort and Report of HIV-1 Infection in a CCR5Δ32 Homozygous Individual
    Oh, Djin-Ye
    Jessen, Heiko
    Kuecherer, Claudia
    Neumann, Konrad
    Oh, Nari
    Poggensee, Gabriele
    Bartmeyer, Barbara
    Jessen, Arne
    Pruss, Axel
    Schumann, Ralf R.
    Hamouda, Osamah
    [J]. PLOS ONE, 2008, 3 (07):
  • [33] CCR5 cell surface density and HIV-1 envelope sequences govern antiretroviral potency of CCR5 antagonists
    Miller, MD
    Lineberger, JE
    Dornadula, G
    Danzeisen, RC
    Blau, CR
    Danovich, RM
    Miller, MA
    Finke, PE
    Oates, BD
    Caldwell, CG
    Chen, P
    Meurer, LC
    Mills, SG
    Springer, MS
    Petropoulos, CJ
    Whitcomb, J
    Huang, W
    Fransen, S
    Simon, AJ
    Hazuda, DJ
    [J]. ANTIVIRAL THERAPY, 2003, 8 (03) : U66 - U67
  • [34] CCR5 and HIV infection
    Blanpain, C
    Libert, F
    Vassart, G
    Parmentier, M
    [J]. RECEPTORS & CHANNELS, 2002, 8 (01): : 19 - 31
  • [35] HIV-1 Resistance to CCR5 Antagonists Associated with Highly Efficient Use of CCR5 and Altered Tropism on Primary CD4+ T Cells
    Pfaff, Jennifer M.
    Wilen, Craig B.
    Harrison, Jessamina E.
    Demarest, James F.
    Lee, Benhur
    Doms, Robert W.
    Tilton, John C.
    [J]. JOURNAL OF VIROLOGY, 2010, 84 (13) : 6505 - 6514
  • [36] Primary genotypic resistance of HIV-1 to CCR5 antagonists in CCR5 antagonist treatment-naive patients
    Soulie, Cathia
    Malet, Isabelle
    Lambert-Niclot, Sidonie
    Tubiana, Roland
    Thevenin, Monique
    Simon, Anne
    Murphy, Robert
    Katlama, Christine
    Calvez, Vincent
    Marcelin, Anne-Genevieve
    [J]. AIDS, 2008, 22 (16) : 2212 - 2214
  • [37] Differential Use of CCR5 by HIV-1 Clinical Isolates Resistant to Small-Molecule CCR5 Antagonists
    Henrich, Timothy J.
    Lewine, Nicolas R. P.
    Lee, Sun-Hee
    Rao, Suhas S. P.
    Berro, Reem
    Gulick, Roy M.
    Moore, John P.
    Tsibris, Athe M. N.
    Kuritzkes, Daniel R.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (04) : 1931 - 1935
  • [38] Interaction of soluble CD4 with the chemokine receptor CCR5
    Wang, XH
    Staudinger, R
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 307 (04) : 1066 - 1069
  • [39] CCR5 promoter activity correlates with HIV disease progression by regulating CCR5 cell surface expression and CD4 T cell apoptosis
    Anjali Joshi
    Erin B. Punke
    Melina Sedano
    Bethany Beauchamp
    Rima Patel
    Cassady Hossenlopp
    Ogechika K. Alozie
    Jayanta Gupta
    Debabrata Mukherjee
    Himanshu Garg
    [J]. Scientific Reports, 7
  • [40] CCR5 promoter activity correlates with HIV disease progression by regulating CCR5 cell surface expression and CD4 T cell apoptosis
    Joshi, Anjali
    Punke, Erin B.
    Sedano, Melina
    Beauchamp, Bethany
    Patel, Rima
    Hossenlopp, Cassady
    Alozie, Ogechika K.
    Gupta, Jayanta
    Mukherjee, Debabrata
    Garg, Himanshu
    [J]. SCIENTIFIC REPORTS, 2017, 7